Company: PFSA
Filing Date: 2025-05-09
Form Type: S-4/A
Source: 0001213900-25-041151
Chunk: 94

Company: Profusa, Inc.
Filing Date: 2025-05-09
Form: S-4/A
Chunk 94
---
     |        As of 
 December 31, 
         2023 |
|:---------------------------------------------------|:----|-------------:|:----|-------------:|
| Shares underlying NorthView’s outstanding warrants |     |   17,404,250 |     |   17,404,250 |
| Milestone Earnout Shares                           |     |    3,875,000 |     |    3,875,000 |
| Outstanding Profusa options                        |     |      855,508 |     |      937,395 |
| Sponsor Inducement Recoupment Shares               |     |            — |     |            — |
| Profusa Inducement Recoupment Shares               |     |            — |     |            — |
|                                                    |     |   22,134,758 |     |   22,216,645 |

•Shares underlying NorthView’s outstanding warrants are not included in the calculation of diluted net loss per share because these shares are contingently issuable, and the contingencies have not yet been met. •Milestone Earnout Shares are not included in the calculation of diluted net loss per share because these shares are contingently issuable, and the contingencies have not yet been met. •Outstanding Profusa options are anti -dilutiveand are not included in the calculation of diluted net loss per share. •Sponsor Inducement Recoupment Shares are excluded because they are expected to be forfeited by the Sponsor upon the closing of the Merger. •Profusa Inducement Recoupment Shares are excluded because they are expected to be forfeited by the Sponsor upon the closing of the Merger.

26 RISK FACTORS In addition to the other information contained in (or incorporated by reference into) this proxy statement/prospectus, including the matters addressed under the heading “Cautionary Note Regarding Forward -Looking Statements,” you should carefully consider the following risk factors in deciding how to vote on the proposals presented in this proxy statement/prospectus. The occurrence of one or more of the events or circumstances described in these risk factors, alone or in combination with other events or circumstances, may have a material adverse effect on Profusa’s and New Profusa’s business, reputation, revenue, financial condition, results of operations and future prospects, in which event the market price of New Profusa Common Stock could decline, and you could lose part or all of your investment. There may be additional risks that neither NorthView nor Profusa presently knows,